Merck & Co. Inc. (MRK): Price and Financial Metrics

Merck & Co. Inc. (MRK): $93.83

0.28 (+0.30%)

POWR Rating

Component Grades














  • MRK scores best on the Growth dimension, with a Growth rank ahead of 93.04% of US stocks.
  • The strongest trend for MRK is in Growth, which has been heading up over the past 179 days.
  • MRK ranks lowest in Momentum; there it ranks in the 8th percentile.

MRK Stock Summary

  • MRK has a higher market value than 98.94% of US stocks; more precisely, its current market capitalization is $206,187,230,241.
  • MRK's went public 36.27 years ago, making it older than 92.84% of listed US stocks we're tracking.
  • In terms of volatility of its share price, MRK is more volatile than only 7.11% of stocks we're observing.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Merck & Co Inc are TXN, INTC, NVS, BMY, and LLY.
  • MRK's SEC filings can be seen here. And to visit Merck & Co Inc's official web site, go to

MRK Valuation Summary

  • MRK's price/earnings ratio is 34.7; this is 4.93% lower than that of the median Healthcare stock.
  • Over the past 243 months, MRK's price/sales ratio has gone up 0.7.
  • Over the past 243 months, MRK's price/sales ratio has gone up 0.7.

Below are key valuation metrics over time for MRK.

Stock Date P/S P/B P/E EV/EBIT
MRK 2021-08-31 4.0 5.8 34.7 30.5
MRK 2021-08-30 4.0 5.8 34.8 30.5
MRK 2021-08-27 4.0 5.8 34.7 30.5
MRK 2021-08-26 4.0 5.8 34.8 30.6
MRK 2021-08-25 4.0 5.9 35.0 30.7
MRK 2021-08-24 4.1 5.9 35.3 31.0

MRK Growth Metrics

    Its 5 year net income to common stockholders growth rate is now at 119.85%.
  • Its 4 year net income to common stockholders growth rate is now at 119.85%.
  • Its 5 year price growth rate is now at 42.55%.
MRK's revenue has moved up $1,356,000,000 over the prior 15 months.

The table below shows MRK's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-12-31 48,704 14,109 13,049
2021-09-30 49,151 13,084 7,197
2021-06-30 48,548 10,460 5,571
2021-03-31 48,018 11,337 7,028
2020-12-31 47,994 10,253 7,067
2020-09-30 47,348 11,041 11,518

MRK's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • MRK has a Quality Grade of B, ranking ahead of 77.57% of graded US stocks.
  • MRK's asset turnover comes in at 0.535 -- ranking 75th of 682 Pharmaceutical Products stocks.
  • XTNT, ACOR, and BDSI are the stocks whose asset turnover ratios are most correlated with MRK.

The table below shows MRK's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.535 0.675 0.129
2021-03-31 0.529 0.670 0.158
2020-12-31 0.538 0.677 0.171
2020-09-30 0.542 0.712 0.276
2020-06-30 0.550 0.701 0.260
2020-03-31 0.571 0.701 0.256

MRK Price Target

For more insight on analysts targets of MRK, see our MRK price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $93.38 Average Broker Recommendation 1.52 (Moderate Buy)

MRK Stock Price Chart Interactive Chart >

Price chart for MRK

MRK Price/Volume Stats

Current price $93.83 52-week high $94.92
Prev. close $93.55 52-week low $70.89
Day low $93.40 Volume 9,067,000
Day high $94.92 Avg. volume 12,211,468
50-day MA $85.57 Dividend yield 2.94%
200-day MA $80.02 Market Cap 237.28B

Merck & Co. Inc. (MRK) Company Bio

Merck & Co., Inc.d.b.a. Merck Sharp & Dohme (MSD) outside the United States and Canada, is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey. It is named after the Merck family, which set up Merck Group in Germany in 1668. Merck & Co. was established as an American affiliate in 1891.(Source:Wikipedia)

MRK Latest News Stream

Event/Time News Detail
Loading, please wait...

MRK Latest Social Stream

Loading social stream, please wait...

View Full MRK Social Stream

Latest MRK News From Around the Web

Below are the latest news stories about Merck & Co Inc that investors may wish to consider to help them evaluate MRK as an investment opportunity.

Iovance (IOVA) Announces Wider-Than-Anticipated Q4 Loss

Iovance Biotherapeutics' (IOVA) fourth-quarter loss is wider than expected. The company is on track to file regulatory submission for lifileucel in melanoma by first-half 2022.

Yahoo | February 25, 2022

10 Stocks to Invest In According to Bart Baum’s Ionic Capital

In this article, we discuss 10 stocks to invest in according to Bart Baum’s Ionic Capital. If you want to skip our detailed analysis of Baum’s history, investment philosophy, and hedge fund performance, go directly to 5 Stocks to Invest In According to Bart Baum’s Ionic Capital. Bart Baum holds a bachelor’s degree in political science […]

Yahoo | February 25, 2022

Merck & Co. Is Honored to Be Named to Forbes America's Best Employers List for the Eighth Year in a Row.

We are honored to have been named to Forbes America's Best Employers list for the eighth year in a row! We were ranked in the top 50 of Overall Best Large Companies this year, and we were ranked se...

Yahoo | February 25, 2022

This Is What Whales Are Betting On Merck & Co

Someone with a lot of money to spend has taken a bearish stance on Merck & Co (NYSE: MRK ). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don''t know. But when something this big happens with MRK, it often means somebody knows something is about to happen. So how do we know what this whale just did? Today, Benzinga ''s options scanner spotted 17 uncommon options trades for Merck & Co. This isn''t normal. The overall sentiment of these big-money traders is split between 29% bullish and 70%, bearish. Out of all of the special options we uncovered, 4 are puts, for a total amount of $134,404, and 13 are calls, for a tot...

Benzinga | February 24, 2022

How companies like Merck and CVS Health are tackling the leaky P&L pipeline

Profit and loss experience is critical to career development, and Paradigm for Parity is launching a program aiming to close that gap for women of color. Read More

Fortune | February 24, 2022

Read More 'MRK' Stories Here

MRK Price Returns

1-mo 10.92%
3-mo 24.82%
6-mo N/A
1-year 23.05%
3-year 27.23%
5-year 68.60%
YTD 23.52%
2021 -2.91%
2020 -7.20%
2019 22.27%
2018 39.95%
2017 -1.49%

MRK Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full MRK Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.4901 seconds.